Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MÜLLER, M. C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2
Export

Selection :

  • and

LE SYSTEME DE LA POSSESSION DANS LA LANGUE PANARE EN ESPAGNOLMULLER M.-C.ANTROPOLOGICA. 1974, Num 38, pp 3-14Article

Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive valueHOCHHAUS, A; MÜLLER, M. C; LAMBERT, A et al.Leukemia. 2009, Vol 23, Num 9, pp 1628-1633, issn 0887-6924, 6 p.Article

Mosaic genome structure of simian immunodeficiency virus from West African green monkeysJIN, M. J; HUXIONG HUI; ROBERTSON, D. L et al.EMBO journal (Print). 1994, Vol 13, Num 12, pp 2935-2947, issn 0261-4189Article

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiaHOCHHAUS, A; O'BRIEN, S. G; MONE, M et al.Leukemia. 2009, Vol 23, Num 6, pp 1054-1061, issn 0887-6924, 8 p.Article

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-CMÜLLER, M. C; GATTERMANN, N; KRAUSE, S. W et al.Leukemia. 2003, Vol 17, Num 12, pp 2392-2400, issn 0887-6924, 9 p.Article

Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probesSAUSSELE, S; WEISSEER, A; MÜLLER, M. C et al.Leukemia. 2000, Vol 14, Num 11, pp 2006-2010, issn 0887-6924Article

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome―Positive LeukemiasCORTES, J. E; KIM, D.-W; DIPERSIO, J et al.The New England journal of medicine. 2013, Vol 369, Num 19, pp 1783-1796, issn 0028-4793, 14 p.Article

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratoriesMÜLLER, M. C; ERBEN, P; HOCHHAUS, A et al.Leukemia. 2008, Vol 22, Num 1, pp 96-102, issn 0887-6924, 7 p.Article

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon αMERX, K; MÜLLER, M. C; HEHLMANN, R et al.Leukemia. 2002, Vol 16, Num 9, pp 1579-1583, issn 0887-6924Article

Simian immunodeficiency viruses from central and Western Africa : evidence for a new species-specific lentivirus in tantalus monkeysMÜLLER, M. C; SAKSENA, N. K; GEORGES-COURBOT, M.-C et al.Journal of virology. 1993, Vol 67, Num 3, pp 1227-1235, issn 0022-538XArticle

Standardized definitions of molecular response in chronic myeloid leukemiaCROSS, Ncp; WHITE, H. E; MÜLLER, M. C et al.Leukemia. 2012, Vol 26, Num 10, pp 2172-2175, issn 0887-6924, 4 p.Article

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesGROSSMANN, V; KOHLMANN, A; HAFERLACH, T et al.Leukemia. 2011, Vol 25, Num 3, pp 557-560, issn 0887-6924, 4 p.Article

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphomaMETZGEROTH, G; WALZ, C; MÜLLER, M. C et al.Leukemia. 2007, Vol 21, Num 6, pp 1183-1188, issn 0887-6924, 6 p.Article

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patientsFRANK, O; BRORS, B; HEHLMANN, R et al.Leukemia. 2006, Vol 20, Num 8, pp 1400-1407, issn 0887-6924, 8 p.Article

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission : Spotlight on imatinib as a model for signal transduction inhibitorsPASCHKA, P; MÜLLER, M. C; GSCHAIDMEIER, H et al.Leukemia. 2003, Vol 17, Num 9, pp 1687-1694, issn 0887-6924, 8 p.Article

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapyHOCHHAUS, A; KREIL, S; GSCHAIDMEIER, H et al.Leukemia. 2002, Vol 16, Num 11, pp 2190-2196, issn 0887-6924Article

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilizationMÜLLER, M. C; MERX, K; WEISSER, A et al.Leukemia. 2002, Vol 16, Num 12, pp 2395-2399, issn 0887-6924, 5 p.Article

CLSM analysis of serotonin-immunoreactive neurons in the central nervous system of Nais variabilis, Slavina appendiculata and Stylaria lacustris (Oligochaeta: Naididae)HESSLING, R; MÜLLER, M. C; WESTHEIDE, W et al.Hydrobiologia (The Hague). 1999, Vol 406, pp 223-233, issn 0018-8158Conference Paper

Cinematographic documentation of enchytraeid morphology and reproductive biologyWESTHEIDE, W; MÜLLER, M. C.Hydrobiologia (The Hague). 1996, Vol 334, Num 1-3, pp 263-267, issn 0018-8158Conference Paper

Bromate ion analysis by ion chromatographyKOUDJONOU, B. K; MÜLLER, M. C; COSTENTIN, E et al.Ozone : science & engineering. 1995, Vol 17, Num 5, pp 561-573, issn 0191-9512Article

La diferenciation linguistica Panare-MapoyaMULLER, M.-C.Antropologica Caracas. 1975, Num 42, pp 79-91Article

Vocabulavo basico de la lengua MapoyaMULLER, M.-C.Antropologica Caracas. 1975, Num 42, pp 57-77Article

La diferenciacion Lingüistica Panare-MapoyaMULLER, M.-C.Antropologica Caracas. 1975, Vol 42, pp 79-91Article

Bilan d'une première expérience HACCP au sein de Générale des Eaux : Le contrôle de la qualité de l'eau = Results of a first HACCP experience at Générale des EauxMULLER, M.-C; DE BEIR, L.TSM. Techniques sciences méthodes, génie urbain génie rural. 2002, Num 12, pp 45-49, issn 0299-7258, 5 p.Article

Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic oneCORTHIER, G; MULLER, M. C.Infection and immunity. 1988, Vol 56, Num 6, pp 1500-1504, issn 0019-9567Article

  • Page / 2